Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study.

Saved in:
Bibliographic Details
Title: Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study.
Authors: Chen JK; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Wei JL; Department of Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China., Yang ZD; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liu SP; Department of Hepatobiliary Surgery, Guigang People's Hospital, Guigang, China., Li ZC; Department of Hepatobiliary Surgery, First Clinical Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China., Chen K; Department of Hepatobiliary Surgery, Second Affiliated Hospital of Guangxi Medical University, Nanning, China., Qin C; Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou, China., Su Z; Department of Hepatobiliary Surgery, First People's Hospital of Nanning, Nanning, China., Ye L; Department of Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China., Li SQ; Department of Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China., Liu GX; Department of Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China., Meng JY; Department of Hepatobiliary Surgery, Wuzhou Workers' Hospital, Wuzhou, China., Wu YH; Department of Oncology, Wuzhou People's Hospital, Wuzhou, China., Quan T; Department of Oncology, Guidong People's Hospital, Wuzhou, China., Li J; Department of Oncology, Wuzhou Red Cross Hospital, Wuzhou, China., Deng ZJ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Yang DL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Su JY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Chen GL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Dong CY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Gu BY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Li WY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Qin XS; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Long XQ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Ma L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Zhong JH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors (Guangxi Medical University), Ministry of Education, Nanning, China.; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Nanning, China.
Corporate Authors: GUIDANCE investigators
Source: Liver cancer [Liver Cancer] 2026 Mar 20. Date of Electronic Publication: 2026 Mar 20.
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer
Database: MEDLINE Ultimate
Description
ISSN:2235-1795
DOI:10.1159/000551629